Okta Inc. diskutieren
Okta, Inc. (NASDAQ: OKTA) had its price target lowered by analysts at KeyCorp from $106.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its price target lowered by analysts at Piper Sandler from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its price target lowered by analysts at Jefferies Financial Group Inc. from $105.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $100.00 to $88.00. They now have a "buy" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its price target lowered by analysts at Wells Fargo & Company from $95.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $100.00 price target on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $100.00 price target on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $100.00 price target on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $90.00 price target on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its price target lowered by analysts at Royal Bank of Canada from $100.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $110.00 price target on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its price target lowered by analysts at Mizuho from $85.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its "buy" rating re-affirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) was upgraded by analysts at Westpark Capital from a "hold" rating to a "buy" rating. They now have a $140.00 price target on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $105.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its price target raised by analysts at Oppenheimer Holdings Inc. from $110.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its price target raised by analysts at Royal Bank of Canada from $95.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its price target raised by analysts at Robert W. Baird from $90.00 to $108.00. They now have an "outperform" rating on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $130.00 price target on the stock.
Ratings data for OKTA provided by MarketBeat
Okta, Inc. (NASDAQ: OKTA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $130.00 price target on the stock.
Ratings data for OKTA provided by MarketBeat
Neueste Beiträge
StockNews_com in Cardinal Health Inc. diskutieren